Pericardial Disease in Cancer Patients

被引:39
作者
Ghosh A.K. [1 ,2 ]
Crake T. [1 ]
Manisty C. [1 ]
Westwood M. [1 ]
机构
[1] Cardio-Oncology Service, Department of Cardiology, Barts Heart Centre, Barts NHS Health Trust, St Bartholomew’s Hospital, West Smithfield, London
[2] Cardio-Oncology Service, Department of Cardiology, University College London Hospital, 235 Euston Road, London
关键词
Cancer; Cardio-oncology; Pericardium;
D O I
10.1007/s11936-018-0654-7
中图分类号
学科分类号
摘要
Purpose of review: To understand the variety of conditions in which the pericardium may be affected in cancer patients. Recent findings: Cancer may affect the pericardium directly (primary cancer; uncommon) or through metastases (commoner). Cancer treatment (chemotherapy and radiotherapy) may affect the pericardium leading to pericarditis and myopericarditis. Pericardial effusions, tamponade and constrictive pericarditis are complications that can also occur. A variety of techniques (predominantly cardiac imaging related) are used to make the diagnosis with the treatment strategy dependent on whether the pericardial disease is due to cancer or as a result of cancer treatment. Summary: A variety of pericardial diseases may be caused by cancer and cancer treatment. Determining the aetiology and providing effective treatment can often be challenging. © 2018, The Author(s).
引用
收藏
相关论文
共 43 条
[1]  
Ghosh A.K., Walker J.M., What you need to know about: Cardio-oncology, (2017)
[2]  
Mody P., Bikdeli B., Wang Y., Imazio M., Krumholz H.M., Trends in acute pericarditis hospitalizations and outcomes among the elderly in the United States, 1999–2012, Eur Hearth J Qual Care Clin Outcomes, 4, pp. 98-105, (2017)
[3]  
Imazio M., Adler Y., Charron P., Recurrent pericarditis: modern approach in 2016, Curr Cardiol Rep, 18, (2016)
[4]  
Imazio M., Gribaudo E., Gaita F., Recurrent pericarditis, Prog Cardiovasc Dis, 59, pp. 360-368, (2017)
[5]  
Imazio M., Gaita F., Acute and recurrent pericarditis, Cardiol Clin, 35, pp. 505-513, (2017)
[6]  
Sogaard K.K., Farkas D.K., Ehrenstein V., Bhaskaran K., Botker H.E., Sorensen H.T., Pericarditis as a marker of occult cancer and a prognostic factor for cancer mortality, Circulation, 136, pp. 996-1006, (2017)
[7]  
Lauk S., Kiszel Z., Buschmann J., Trott K.R., Radiation-induced heart disease in rats, Int J Radiat Oncol Biol Phys, 11, pp. 801-808, (1985)
[8]  
McGale P., Darby S.C., Hall P., Adolfsson J., Bengtsson N.O., Bennet A.M., Et al., Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden, Radiother Oncol, 100, pp. 167-175, (2011)
[9]  
Hardenbergh P.H., Munley M.T., Bentel G.C., Kedem R., Borges-Neto S., Hollis D., Et al., Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results, Int J Radiat Oncol Biol Phys, 49, pp. 1023-1028, (2001)
[10]  
Darby S.C., Ewertz M., McGale P., Bennet A.M., Blom-Goldman U., Bronnum D., Et al., Risk of ischemic heart disease in women after radiotherapy for breast cancer, N Engl J Med, 368, pp. 987-998, (2013)